Top Eminent Healthcare Group (HKSE:06877) Return-on-Tangible-Equity: 1.13% (As of Jun. 2026) — 79% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Top Eminent Healthcare Group Return-on-Tangible-Equity?

Top Eminent Healthcare Group HKSE:06877 +3.16% Return-on-Tangible-Equity is 1.13% as of Jun. 2026, which is 79% above its 10-year median of 0.63. The stock has 1 warning sign investors should review. Among 774 Capital Markets companies, Top Eminent Healthcare Group ranks worse than 75.45% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Top Eminent Healthcare Group's annualized net income for the quarter that ended in Jun. 2026 was HK$2.7 Mil. Top Eminent Healthcare Group's average shareholder tangible equity for the quarter that ended in Jun. 2026 was HK$241.7 Mil. Therefore, Top Eminent Healthcare Group's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 1.13%.

The historical rank and industry rank for Top Eminent Healthcare Group's Return-on-Tangible-Equity or its related term are showing as below:

HKSE:06877' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -39.18   Med: 0.63   Max: 8.19
Current: -1.45

During the past 13 years, Top Eminent Healthcare Group's highest Return-on-Tangible-Equity was 8.19%. The lowest was -39.18%. And the median was 0.63%.

HKSE:06877's Return-on-Tangible-Equity is ranked worse than
75.45% of 774 companies
in the Capital Markets industry
Industry Median: 6.755 vs HKSE:06877: -1.45

Top Eminent Healthcare Group  (HKSE:06877) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Top Eminent Healthcare Group Return-on-Tangible-Equity Related Terms


Top Eminent Healthcare Group Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Top Eminent Healthcare Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Top Eminent Healthcare Group Return-on-Tangible-Equity Chart

Top Eminent Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.79 -12.43 4.18 4.68 -2.93

Top Eminent Healthcare Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.16 4.15 -1.80 -4.01 1.13

HKSE:06877 vs MS, GS, SCHW: Return-on-Tangible-Equity Comparison

For the Capital Markets subindustry, Top Eminent Healthcare Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Top Eminent Healthcare Group Return-on-Tangible-Equity vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Top Eminent Healthcare Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Top Eminent Healthcare Group's Return-on-Tangible-Equity falls into.



Top Eminent Healthcare Group Return-on-Tangible-Equity Calculation

Top Eminent Healthcare Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-7.114/( (244.307+240.683 )/ 2 )
=-7.114/242.495
=-2.93 %

Top Eminent Healthcare Group's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2026 )  (Q: Dec. 2025 )(Q: Jun. 2026 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2026 )  (Q: Dec. 2025 )(Q: Jun. 2026 )
=2.738/( (240.683+242.8)/ 2 )
=2.738/241.7415
=1.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2026) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 1.13% mean?
Top Eminent Healthcare Group (HKSE:06877) has a Return-on-Tangible-Equity of 1.13% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Top Eminent Healthcare Group and its competitors. This is 79% above median its historical median of 0.63. According to the industry distribution chart, Top Eminent Healthcare Group ranks #584 out of 774 companies in the Capital Markets industry, placing it in the top 75.5%.
Is Top Eminent Healthcare Group's Return-on-Tangible-Equity too high?
Top Eminent Healthcare Group's current Return-on-Tangible-Equity of 1.13% is 79% above median its 10-year median of 0.63. The Capital Markets industry median Return-on-Tangible-Equity is 6.76. Top Eminent Healthcare Group's value of 1.13% is 83.3% below this industry median. Based on the distribution chart, Top Eminent Healthcare Group ranks #584 out of 774 companies in the Capital Markets industry, which is in the bottom quartile relative to peers.
How does Top Eminent Healthcare Group's Return-on-Tangible-Equity compare to MS and GS?
According to the Capital Markets industry distribution chart, Top Eminent Healthcare Group ranks #584 out of 774 companies for Return-on-Tangible-Equity. This places Top Eminent Healthcare Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 6.76. Top Eminent Healthcare Group's value of 1.13% is 83.3% below this benchmark. While the company's 10-year median is 0.63 vs. the industry median of 6.76, Top Eminent Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Capital Markets company?
The median Return-on-Tangible-Equity among Capital Markets companies is 6.76, based on 774 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Top Eminent Healthcare Group's current Return-on-Tangible-Equity of 1.13% is 83.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Top Eminent Healthcare Group and its competitors. For the Capital Markets industry, the median Return-on-Tangible-Equity is 6.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Top Eminent Healthcare Group's current Return-on-Tangible-Equity is 1.13%, which is 79% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Top Eminent Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Top Eminent Healthcare Group (HKSE:06877) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.10 — trading 30% below its estimated fair value. The current Return-on-Tangible-Equity is 1.13%, which is 79% above median its 10-year median of 0.63 and 83.3% below the Capital Markets industry median of 6.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Top Eminent Healthcare Group (HKSE:06877), the current Return-on-Tangible-Equity is 1.13% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Top Eminent Healthcare Group Business Description

Address 88 Queensway, Suite 810, Level 8, One Pacific Place, Hong Kong, HKG
Top Eminent Healthcare Group Ltd formerly CLSA Premium Ltd operates in the financial services sector. It provides leveraged forex and other trading, cash dealing, sales of healthcare products, and other services.. The operating segments of the group are the Margin dealing segment. Unallocated segment, Healthcare products segment, The margin dealing segment is engaged in the provision of leveraged foreign exchange, commodity, and index trading services in Australia, Hong Kong, and New Zealand. The healthcare products segment engages in the sales of healthcare products. It has a business presence in Hong Kong, Australia, New Zealand, and Other countries.